Literature DB >> 10817651

Anticipation in inflammatory bowel disease: a phenomenon caused by an accumulation of confounders.

J Hampe1, K Heymann, W Kruis, A Raedler, U R Fölsch, S Schreiber.   

Abstract

Inflammatory bowel disease (IBD) has a definite genetic component as documented by epidemiological and linkage evidence. It shows an earlier onset of disease in children of affected patients than in their parents. This has lead to speculations about genetic anticipation in this disorder. 2,007 IBD patients with sporadic disease and 472 multiplex familial cases (including 103 affected parents and 99 children of affected patients) were evaluated with a multi-item questionnaire as part of a study of inflammatory bowel disease genetics. The Mann-Whitney U-test and the general linear model were used for analysis. Clinical characteristics such as presence of fistulae, stenoses, extraintestinal manifestations, and other parameters, which are related to the severity of the disease, were found to be similar between familial and sporadic cases of IBD (corrected P > or = 0.31 for all tests). The mean-age-of onset in children of affected patients was 19.4 years earlier than in their parents. However, the age of the parental cohort was significantly higher (27 years) and the diagnostic interval also longer (1.7 years). If these confounders are corrected in a general linear model, no significant difference is evident for the age-of-onset between the groups (P > or = 0.52). There is no evidence for genetic anticipation in inflammatory bowel disease. The absence of genetic anticipation is consistent with the clinical similarity of familial and sporadic inflammatory bowel disease. This finding justifies the primary genetic analysis of familial disease under the assumption that their genetic background will be representative for all presentations of IBD.

Entities:  

Mesh:

Year:  2000        PMID: 10817651     DOI: 10.1002/(sici)1096-8628(20000529)92:3<178::aid-ajmg4>3.0.co;2-p

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 2.  Family and twin studies in inflammatory bowel disease.

Authors:  Leena Halme; Paulina Paavola-Sakki; Ulla Turunen; Maarit Lappalainen; Martti Farkkila; Kimmo Kontula
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 3.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 4.  Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors:  Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

Review 5.  The complexity and challenges of genetic counseling and testing for inflammatory bowel disease.

Authors:  Shelly A Cummings; David T Rubin
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

6.  Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.

Authors:  Sook Hee Chung; Soo Jung Park; Hye Sun Lee; Sung Pil Hong; Jae Hee Cheon; Tae Il Kim; Won Ho Kim
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 7.  Epidemiology of intrafamilial inflammatory bowel disease throughout Europe.

Authors:  Maria Teresa Arias-Loste; Beatriz Castro; Montserrat Rivero; Javier Crespo
Journal:  Ann Gastroenterol       Date:  2012

Review 8.  Familial and ethnic risk in inflammatory bowel disease.

Authors:  Maria Pia Costa Santos; Catarina Gomes; Joana Torres
Journal:  Ann Gastroenterol       Date:  2017-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.